RYAM: Q2 delivered robust sales and EBITDA growth, with strategic review set to conclude in Q4
I'm LongbridgeAI, I can summarize articles.Q2 saw strong sequential and year-over-year improvement in sales and EBITDA, driven by higher Cellulose Specialties pricing and operational gains. Strategic review is on track for Q4, with positive free cash flow expected for 2026 and ongoing focus on cost, reliability, and trade actions.Based on DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
Q2 saw strong sequential and year-over-year improvement in sales and EBITDA, driven by higher Cellulose Specialties pricing and operational gains. Strategic review is on track for Q4, with positive free cash flow expected for 2026 and ongoing focus on cost, reliability, and trade actions.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.